JCM
ORTX

Jacobi Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Jacobi Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50
Closed -$1K – 1398
2021
Q3 		$1K Hold
50
– – ﹤0.01% 1426
2021
Q2 		$2K Hold
50
– – ﹤0.01% 1293
2021
Q1 		$4K Buy
+50
New +$3.55K ﹤0.01% 1175

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Jacobi Capital Management's ORTX Position: Q4 2021 in Review

Jacobi Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 50 shares — an estimated $1K sold.

Jacobi Capital Management first reported a position in ORTX in Q1 2021 and held it in 3 quarters. The position peaked at $4K in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • Jacobi Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 50 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $1K.
  • Jacobi Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 3 quarters.
  • Jacobi Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $4K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.